Advertisement
Screener

Dare Bioscience, Inc. (DARE) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Dare Bioscience, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Dare Bioscience, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $9.89M went out.
  • Fiscal year ended 2025-12-31: from investing, $385.28K went out.
  • Fiscal year ended 2025-12-31: from financing, $19.28M came in.
  • Fiscal year ended 2025-12-31: change in cash, $9.01M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$9.89M-$385.28K$20.93M-$1.65M*$9.01M
2024-12-31$5.47M-$573.05K$453.58K$5.19M
2023-12-31-$38.86M-$629.43K$0.00$15.64M*-$23.86M
2022-12-31-$18.09M-$63.07K$1.30M-$17.00M
2021-12-31-$28.76M-$14.52K$16.30M$59.55M*$47.00M
2020-12-31-$25.23M-$17.63K$22.98M$2.15M*-$110.64K
2019-12-31-$13.32M$6.14M$5.15M-$2.03M
2018-12-31-$10.27M-$518.84K$10.11M*-$753.96K
2017-12-31-$2.54M$9.92M$7.52M
2016-12-31-$372.30K$0.00-$174.80K
2015-12-31-$31.91M-$484.00K$2.63M$54.51M*$24.73M
2014-12-31-$19.06M-$185.00K$140.00K$64.79M*$45.69M
2013-12-31-$16.61M-$7.00K$35.00K$5.37M*-$11.22M
2012-12-31-$21.00M-$180.00K$3.00K$22.54M*$1.36M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$6.78M*-$80.59K*$166.70K*$784.52K*
2026-03-31-$5.52M$0.00$94.89K-$810.36K*-$6.19M
2025-12-31$1.44M*-$206.64K*
2025-09-30-$442.13K*-$174.70K*$18.65M*
2025-06-30-$5.42M*$153.40K*$475.01K*
2025-03-31-$5.47M-$157.33K$436.25K-$5.37M
2024-12-31$5.31M*-$562.85K*
2024-09-30-$5.92M*$282.32K*
2024-06-30$12.90M*-$285.23K*
2024-03-31-$6.81M-$7.30K-$6.85M
2023-12-31-$8.18M*-$607.33K*$0.00*$5.31M*
2023-09-30-$7.97M*-$22.10K*$8.58M*
2023-06-30-$6.59M*$0.00*
2023-03-31-$16.12M$0.00$1.30M*-$14.84M
2022-12-31-$5.90M*-$2.70K*-$1.00*
2022-09-30$8.60M*-$55.00K*$0.00*
2022-06-30-$8.45M*-$816.00*$1.34M*
2022-03-31-$12.34M-$4.55K-$12.36M
2021-12-31-$9.92M*$0.00*$9.30M*$6.70M*
2021-09-30$1.32M*-$14.52K*$36.20M-$983.49K*
2021-06-30-$11.79M*$0.00*$13.25M*
2021-03-31-$8.38M$0.00$11.37M*$2.99M
2020-12-31-$9.19M*-$2.38K*$8.45M*
2020-09-30-$5.36M*$0.00*$5.40M*
2020-06-30-$4.09M*$4.39M*
2020-03-31-$6.60M$6.89M*$267.22K
2019-12-31-$3.81M*$6.14M*
2019-09-30-$3.18M*$0.00*
2019-06-30-$3.02M*$5.15M*
2019-03-31-$3.31M-$3.30M
2018-12-31-$2.71M*$0.00*-$2.73M*
2018-09-30-$2.75M*-$58.64K*-$2.91M*
2018-06-30-$2.69M*-$3.18M*
2018-03-31-$2.12M$10.10M$8.07M
2017-12-31-$961.07K*$0.00*-$969.37K*
2017-09-30-$1.42M*$9.92M*$8.49M*
2017-06-30-$109.61K*-$1.50M*$8.00K*-$54.61K*
2017-03-31-$50.59K$1.50M$62.00K$49.41K
2016-12-31-$166.95K*$382.00K*$840.00K*$5.16M*$30.55K*
2016-09-30-$22.84K*-$382.00K*$37.00K*-$1.99M*$28.51M*
2016-06-30$13.08M*$242.00K*$0.00*-$1.97M*-$13.32M*
2016-03-31-$13.26M-$242.00K$41.00K-$1.93M*-$15.39M
2015-12-31-$8.21M*-$113.00K*$0.00*$6.60M*-$1.72M*
2015-09-30-$7.97M*-$34.00K*$156.00K*-$7.84M*
2015-06-30-$7.80M*-$308.00K*$61.00K*$37.20M*$29.16M*
2015-03-31-$7.94M-$29.00K$2.41M$10.70M*$5.14M
2014-12-31-$5.61M*-$109.00K*$0.00*-$895.00K*-$6.61M*
2014-09-30-$5.56M*-$78.00K*$7.00K*-$856.00K*-$6.49M*
2014-06-30-$4.23M*$6.00K*$106.00K*$59.92M*$55.80M*
2014-03-31-$3.67M-$4.00K$27.00K$6.62M*$2.98M
2013-12-31-$3.27M*$0.00*$19.00K*-$1.17M*-$4.42M*
2013-09-30-$3.22M*-$2.00K*$0.00*$8.05M*$4.82M*
2013-06-30-$5.52M*-$3.00K*$0.00*-$763.00K*-$6.29M*
2013-03-31-$4.60M-$2.00K$16.00K-$748.00K*-$5.34M

Similar stocks

Stock NameCountryMarket CapPE Ratio
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Moleculin Biotech, Inc. (MBRX)United States$0.011B
MetaVia Inc. (MTVA)United States$0.011B-0.65
KALA BIO, Inc. (KALA)United States$0.011B-3.33
BIOVIE INC. (BIVI)United States$0.012B
Theriva Biologics, Inc. (TOVX)United States$0.011B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60